1[1]O' Donnell CJ, Lindpaintner K, Larson MG, et al. Evidence for as sociation and genetic linkage of the angiotensincoverting enzyme locus with hypertension and blood pressure in men but not women in the framingham heart study. Circulation,1998;97:1766
2[2]Fomicheva EV, Gukova SP, Larionova-Vasina Ⅵ, et al.Gene-gene interaction in the RAS in the predisposition to myocardial infarction in elder population of St. Peterburg (Russia).Mol Genet Metab, 2001; 69( 1 ): 76
3[3]Keidar S, Kaplan M, Shapira L, et al. Low density lipoprotein isolated from patient with essential hypertension: a possible role for angiotensin Ⅱ. Atherosclerosis, 1994; 107:71
4[4]Jeunematine X, Soubrier F, Kotelevtser Y, et al. Molecular basis of human hypertension: role of angiotensiogen. Cell, 1992;71:169
5[5]Hyung-Suk Kim, Kerge JH, et al. Genetic control of blood pressure and the angiotensinogen locus. Natl Acad Sci USA,1995; 92: 2735
7[7]Bonnardeaux A, Davies E, Jeunemaitre X, et al. Angiotensin Ⅱ type 1 receptor gene polymorphisms in human essential hypertension. Hypertension, 1994; 24: 63
8[8]Schmieder RE, Erdmann J, Delles C, et al. Effect of the angiotensin Ⅱ type 2-receptor ( + 1675G/A) on left ventricular structure in humans. J Am Coll Cardiol, 2001;37(1): 175
9[9]Timmermann B, Mo R, Luft FC, et al. Beta-2 adrenoceptor genetic variation is ussociated with genetic predisposition to essential hypertension, The Bergen Blood Pressure study. Kidney Int, 1998;53:1455
10[10]Xie HG, Stein CM, Kim RB, et al. Human beta 2-adrenogin receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther, 2000; 67: 670
